Position in NVAX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,489,556
+$433,392 QoQ
Shares Held
158,127
+21.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,189,780,209 across 296 Biotechnology names. NVAX ranks #126 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,489,556 | 158,127 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,056,164 | 129,750 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $805,889 | 119,924 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $997,222 | 115,020 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $635,909 | 100,938 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $748,155 | 116,717 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $993,590 | 123,581 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,058,318 | 83,794 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $825,710 | 65,222 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $276,374 | 57,819 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $221,601 | 46,167 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $339,577 | 46,903 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $307,512 | 41,388 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $94,648 | 13,658 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $738,770 | 71,865 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,215,413 | 66,781 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,007,680 | 77,925 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $14,574,007 | 197,882 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $24,585,862 | 171,845 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $24,478,953 | 118,079 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $25,481,868 | 120,022 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $13,546,937 | 74,717 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,587,159 | 77,008 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,355,667 | 40,200 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,868,904 | 34,420 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $140,810 | 10,369 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||